* ALPHELYS *
2001 - IDF
Plaisir
(near Paris)
www.alphelys.com Design, Solutions
Key words: Instruments, Tissue array, Molecular histology, Imaging, Software, Reagents, Tisalys, Cresalys, MiniCore
Mission: to design, develop and market innovative integrated solutions including instruments, software and reagents for pathology and cytogenetics markets
Clients: Pharmaceutical industry, Research labs
info@alphelys.com
Age: 8 year(s)
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS | | Personal venture |
Managing Dir.-CEO: Chaumat (Pierre) [co-founder, born 1965]
Sc.Dir.-CSO:
SalesMktg: Defrenaix (Pierre) [co-founder]
Fin.Dir.-CFO:
BusDev:
Financers (Hist.): none (100% privately owned, capital 2007 = 0.04 M€, 2006 = 0.11 M€) | Turnover (M€) : 2.0 (2007)
Total funding (M€) : 0.4
Last funding (M€) : n.a.
Focus : Multiple
Position : Preclin
Company confirm : none |
History | DATE | MILESTONE | TYPE | TIME | | 2009 .12 | Partnering distribution agreement with Biogen (USA) for Brazil market (exclusive distributor) | MKTG | [8 years] |
| 2008 .05 | Partnering distribution agreement with Zytomed Systems (Germany) for immunohistochemical reagents in France | MKTG | [6 years] |
| 2006 .10 | Partnering distribution agreement with Seroa (Monaco) for product portfolio in many countries worldwide | MKTG | [5 years] |
| 2005 .06 | Seed financing : 0.24 M€, by owners, as a capital increase from 0.16 M€ to 0.40 M€ | SFIN | [3 years] |
| 2002 .02 | Company name change from Amelys to Alphelys, due to pre-occupied name | INFO | [0 year] |
| 2001 .10 | Company founded by Pierre Chaumat and Pierre Defrenaix (initially named Amelys) | ORGF | [0 year] | Actualisation / Updating: 04-Janv-2010 |
|
